Your browser doesn't support javascript.
loading
Crystal structure of aurora-2, an oncogenic serine/threonine kinase.
Cheetham, Graham M T; Knegtel, Ronald M A; Coll, Joyce T; Renwick, Suzanne B; Swenson, Lora; Weber, Peter; Lippke, Judith A; Austen, Douglas A.
Afiliação
  • Cheetham GM; Vertex Pharmaceuticals (Europe) Ltd., 88 Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom. cheetham@vpharm.com
J Biol Chem ; 277(45): 42419-22, 2002 Nov 08.
Article em En | MEDLINE | ID: mdl-12237287
ABSTRACT
Aurora-2 is a key member of a closely related subgroup of serine/threonine kinases that plays important roles in the completion of essential mitotic events. Aurora-2 is oncogenic and amplified in various human cancers and could be an important therapeutic target for inhibitory molecules that would disrupt the cell cycle and block proliferation. We report the first crystal structure of Aurora-2 kinase in complex with adenosine. Analysis of residues in the active site suggests differences with structurally and biologically related protein kinases. The activation loop, which contains residues specific to the Aurora family of kinases, has a unique conformation. These results provide valuable insight into the design of selective and highly potent ATP-competitive inhibitors of the Aurora kinases.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases Limite: Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases Limite: Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article